Moreover, the knockdown of SESN2 enhanced phosphorylation of S6 and p70S6K proteins (Figure 2F), indicating SESN2 expression to negatively regulate mTORC1 activity in endometrial cancer. Here, SESN2 is linked to endometrial cancer.